Search results for "6(48)"

showing 10 items of 102 documents

Psychometric evaluation of the Persian version of the diabetic foot self-care questionnaire in Iranian patients with diabetes

2021

AbstractBackgroundDiabetic foot self-care refers to a group of self-management behaviors that can reduce the incidence of foot ulcers and amputations. It is necessary to have a valid and reliable standard tool to measure foot self-care in diabetic patients. This study aimed to evaluate the psychometric properties of the Persian version of the Diabetic Foot Self-Care Questionnaire of the University of Malaga, Spain (DFSQ-UMA) in Iran.MethodsThis cross-sectional study was conducted with 407 diabetic patients who were selected using a convenient sampling method. Construct validity was assessed by exploratory (with 207 patients) and confirmatory (with 200 patients) factor analyses. Internal con…

AdultMalemedicine.medical_specialtyPsychometricsPsychometricsEndocrinology Diabetes and MetabolismValidity030209 endocrinology & metabolismIranDiseases of the endocrine glands. Clinical endocrinology03 medical and health sciencesDiabetic foot self-care0302 clinical medicineCronbach's alphaInfermeriaSurveys and QuestionnairesDiabetes mellitusDiabetes MellitusmedicineHumans030212 general & internal medicineAgedAged 80 and overbusiness.industryDiabetesPersiaReproducibility of ResultsConstruct validityGeneral MedicineMiddle AgedRC648-665medicine.diseaseDiabetic footDiabetic FootExploratory factor analysisSelf CareCross-Sectional StudiesPhysical therapyFemaleSelf-carebusinessFoot (unit)Research Article
researchProduct

Diabetic foot syndrome as a possible cardiovascular marker in diabetic patients

2015

Diabetic foot ulcerations have been extensively reported as vascular complications of diabetes mellitus associated with a high degree of morbidity and mortality; in fact, some authors showed a higher prevalence of major, previous and new-onset, cardiovascular, and cerebrovascular events in diabetic patients with foot ulcers than in those without these complications. This is consistent with the fact that in diabetes there is a complex interplay of several variables with inflammatory metabolic disorders and their effect on the cardiovascular system that could explain previous reports of high morbidity and mortality rates in diabetic patients with amputations. Involvement of inflammatory marke…

AdultMalemedicine.medical_specialtySettore MED/09 - Medicina InternaEndocrinology Diabetes and MetabolismInflammationType 2 diabetesReview ArticleCardiovascular Systemlcsh:Diseases of the endocrine glands. Clinical endocrinologyEndocrinologyRisk FactorsDiabetes mellitusInternal medicinemedicineAlbuminuriaAnimalsHumansAgedDyslipidemiasInflammationlcsh:RC648-665Adiponectinbusiness.industryInterleukin-6Mortality rateMiddle Agedmedicine.diseaseDiabetic footDiabetic FootEndocrinologyDiabetes Mellitus Type 2Cardiovascular DiseasesImmune SystemHypertensionAlbuminuriaResistinFemalemedicine.symptombusinessdiabetic foot inflammation marker
researchProduct

Anaplastic Thyroid Carcinoma: A ceRNA Analysis Pointed to a Crosstalk between SOX2, TP53, and microRNA Biogenesis.

2014

It has been suggested that cancer stem cells (CSC) may play a central role in oncogenesis, especially in undifferentiated tumours. Anaplastic thyroid carcinoma (ATC) has characteristics suggestive of a tumour enriched in CSC. Previous studies suggested that the stem cell factorSOX2has a preeminent hierarchical role in determining the characteristics of stem cells in SW1736 ATC cell line. In detail, silencing SOX2 in SW1736 is able to suppress the expression of the stem markers analysed, strongly sensitizing the line to treatment with chemotherapeutic agents. Therefore, in order to further investigate the role of SOX2 in ATC, a competing endogenous RNA (ceRNA) analysis was conducted in order…

Article SubjectEndocrinology Diabetes and MetabolismSOX2Stem cell factorAnaplastic Thyroid carcinomaBiologyBioinformaticsmedicine.disease_causelcsh:Diseases of the endocrine glands. Clinical endocrinologySettore MED/13 - EndocrinologiaEndocrinologySOX2Cancer stem cellmicroRNAmedicineGene silencinglcsh:RC648-665microRNAEndocrine and Autonomic SystemsCompeting endogenous RNAceRNACancer researchStem cellCarcinogenesisResearch ArticleInternational journal of endocrinology
researchProduct

GLP-1 Receptor Agonists and Cardiovascular Disease in Patients with Type 2 Diabetes

2018

Diabetes mellitus is a chronic disease prevalence of which is high and continually growing. Cardiovascular disease continues to be the leading cause of death in patients with T2DM. The prevention of cardiovascular complications and the cardiovascular safety of treatments should be a primary objective when selecting treatment. Among all the drugs available, the compounds known as glucagon-like peptide-1 receptor agonists (GLP-1 RAs) appear to be not just innocuous in terms of CVD but indeed to be beneficial. GLP-1 RA actions not only translate on an improvement of well-known cardiovascular risk factors such as glycaemic control, dyslipidaemia, weight, or arterial hypertension but also might …

Blood GlucoseEndocrinology Diabetes and Metabolism030209 endocrinology & metabolismType 2 diabetesDiseaseReview Article030204 cardiovascular system & hematologyBioinformaticslcsh:Diseases of the endocrine glands. Clinical endocrinologyIncretinsGlucagon-Like Peptide-1 Receptor03 medical and health sciences0302 clinical medicineEndocrinologyDiabetes mellitusmedicineHumansHypoglycemic AgentsCause of deathSistema cardiovascularlcsh:RC648-665DiabetisLiraglutidebusiness.industrySemaglutidemedicine.diseaseClinical trialDiabetes Mellitus Type 2Cardiovascular DiseasesHeart failureMalaltiesbusinessmedicine.drugJournal of Diabetes Research
researchProduct

Asperuloside Enhances Taste Perception and Prevents Weight Gain in High-Fat Fed Mice

2021

Asperuloside is an iridoid glycoside found in many medicinal plants that has produced promising anti-obesity results in animal models. In previous studies, three months of asperuloside administration reduced food intake, body weight, and adipose masses in rats consuming a high fat diet (HFD). However, the mechanisms by which asperuloside exerts its anti-obesity properties were not clarified. Here, we investigated homeostatic and nutrient-sensing mechanisms regulating food intake in mice consuming HFD. We confirmed the anti-obesity properties of asperuloside and, importantly, we identified some mechanisms that could be responsible for its therapeutic effect. Asperuloside reduced body weight …

Blood GlucoseLeptinMalecannabinoid (CB) receptor 10301 basic medicineTastePro-Opiomelanocortinfood intakeEndocrinology Diabetes and MetabolismAdipose tissueWeight Gainnutrient-sensing mechanismslcsh:Diseases of the endocrine glands. Clinical endocrinologyCyclopentane MonoterpenesEnergy homeostasisMiceEndocrinology0302 clinical medicineGlucosidesWeight lossInsulinasperuloside; cannabinoid (CB) receptor 1; CD36; FFAR1-4; food intake; nutrient-sensing mechanisms; TAS1R2-3; weight lossReceptorOriginal ResearchLeptindigestive oral and skin physiologyTaste PerceptionGhrelinTAS1R2-3Ghrelinmedicine.symptommedicine.medical_specialtyHypothalamusBiologyDiet High-Fatasperuloside03 medical and health sciencesInternal medicinemedicineAnimalsPyranslcsh:RC648-665Body WeightFFAR1-4030104 developmental biologyEndocrinologyAnti-Obesity Agentsweight lossEnergy IntakeCD36Weight gain030217 neurology & neurosurgery
researchProduct

Timing of Exercise Affects Glycemic Control in Type 2 Diabetes Patients Treated with Metformin

2018

Objective. The purpose of the study was to examine the acute effects of the timing of exercise on the glycemic control during and after exercise in T2D. Methods. This study included 26 T2D patients (14 women and 12 men) who were treated with metformin. All patients were tested on four occasions: metformin administration alone (Metf), high-intensity interval training (HIIT) performed at 30 minutes (EX30), 60 minutes (EX60), and 90 minutes (EX90) postbreakfast, respectively. Glucose, insulin, and superoxide dismutase (SOD) activity were examined. Results. Glucose decreased significantly after the exercise in EX30, EX60, and EX90. Compared with Metf, the decline in glucose immediately after th…

Blood GlucoseMaleTime Factorsendocrine system diseasesEndocrinology Diabetes and Metabolismmedicine.medical_treatmentmetformiiniajoitus (suunnittelu)Type 2 diabetes030204 cardiovascular system & hematologyHigh-Intensity Interval TrainingGastroenterologylcsh:Diseases of the endocrine glands. Clinical endocrinologyInterval training0302 clinical medicineEndocrinologyInsulinta315type 2 diabetes patientskuntoliikuntata3141Middle Agedtiming of exerciseMetforminFemaleHigh-intensity interval trainingmedicine.drugAdultmedicine.medical_specialtyArticle Subject030209 endocrinology & metabolism03 medical and health sciencesInternal medicineDiabetes mellitusmedicineHumansHypoglycemic AgentsExercise physiologyExerciseGlycemiclcsh:RC648-665business.industrySuperoxide DismutaseInsulinmedicine.diseaseDiabetes Mellitus Type 2verensokeriClinical Studyglycemic controlbusinessmetforminaikuistyypin diabetesJournal of Diabetes Research
researchProduct

Efficacy and Renal Safety of Dapagliflozin in Patients with Type 2 Diabetes Mellitus Also Receiving Metformin: A Real-Life Experience.

2017

Introduction. This study aimed at evaluating the efficacy and safety of dapagliflozin in patients with type 2 diabetes (T2D) who also received metformin in clinical practice in Italy. Methods. This was a retrospective observational study and it included data from patients who received dapagliflozin 10 mg once daily in conjunction with metformin for 12 months (DAPA + MET). In those with inadequate glycemic control, insulin or glimepiride was added after 30 days (DAPA + MET + other glucose-lowering drugs). Efficacy assessments included glycosylated hemoglobin (HbA1c) levels at 6 and 12 months, as well as body mass index (BMI) and lipid parameters at 12 months. Safety was also assessed. Result…

Blood GlucoseMalemedicine.medical_specialtyArticle Subjectendocrine system diseasesEndocrinology Diabetes and Metabolism030209 endocrinology & metabolismType 2 diabeteslcsh:Diseases of the endocrine glands. Clinical endocrinologyBody Mass Index03 medical and health scienceschemistry.chemical_compound0302 clinical medicineEndocrinologyGlucosidesInternal medicineDiabetes mellitusmedicineHumansHypoglycemic Agents030212 general & internal medicineDapagliflozinBenzhydryl CompoundsAgedRetrospective StudiesGlycated Hemoglobinlcsh:RC648-665business.industryType 2 Diabetes Mellitusnutritional and metabolic diseasesRetrospective cohort studyMiddle Agedmedicine.diseaseMetforminMetforminTreatment OutcomechemistryDiabetes Mellitus Type 2Observational studyDrug Therapy CombinationFemalebusinessBody mass indexmedicine.drugResearch ArticleJournal of diabetes research
researchProduct

Siglo de la piedad y el Patriarcha aragones el Bo. Joseph de Calasanz fundador de las Escuelas Pias

Segons Herrera Navarro, Fernando de Heredia pot ser pseudònim de l'escolapi José de San Joaquín Sign.: A-G4 Text a dues col., separades per filet Reclams

Calassanç Josep de sant 1557-1648 Obres anteriors al 1800Teatre castellà S.XVIII Obres anteriors al 1800
researchProduct

Crida, 1647, 12, 14

1647

Com a tít. el començament del text Sign. : A2 Reclam

Censals Comunitat Valenciana S. XVII Obres anteriors al 1800Pesta bubònica València (Comunitat Valenciana) 1647-1648 Obres anteriors a 1800Censals València (Comunitat valenciana) S.XVII Obres anteriors a 1800Pesta bubònica Comunitat Valenciana 1647-1648 Obres anteriors al 1800
researchProduct

Editorial: Stem Cells in Endocrine Tumors

2021

Endocrine Tumorcancer stem cells (CSCs)business.industryEndocrinology Diabetes and Metabolismendocrine tumorEMTRC648-665Diseases of the endocrine glands. Clinical endocrinologyCancer researchEmt ; Biomarker ; Cancer Stem Cells (cscs) ; Endocrine Tumor ; Tumor MetabolismEndocrine systemMedicineBiomarker (medicine)biomarkerendocrine tumours cancer stem cells metabolic reprogramming EMT.tumor metabolismStem cellSettore MED/46 - Scienze Tecniche Di Medicina Di LaboratoriobusinessFrontiers in Endocrinology
researchProduct